NanoViricides, Inc. (NNVC)

NanoViricides Statistics

Total Valuation

NanoViricides has a market cap or net worth of $40.55 million. The enterprise value is $31.19 million.

Market Cap	40.55M
Enterprise Value	31.19M

Important Dates

The last earnings date was Friday, May 15, 2026, before market open.

Earnings Date	May 15, 2026
Ex-Dividend Date	n/a

Share Statistics

NanoViricides has 22.78 million shares outstanding. The number of shares has increased by 32.11% in one year.

Current Share Class	22.78M
Shares Outstanding	22.78M
Shares Change (YoY)	+32.11%
Shares Change (QoQ)	+8.86%
Owned by Insiders (%)	0.56%
Owned by Institutions (%)	8.34%
Float	22.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.57
P/TBV Ratio	3.89
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.17

Current Ratio	3.17
Quick Ratio	3.02
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -89.97% and return on invested capital (ROIC) is -56.82%.

Return on Equity (ROE)	-89.97%
Return on Assets (ROA)	-50.46%
Return on Invested Capital (ROIC)	-56.82%
Return on Capital Employed (ROCE)	-89.32%
Weighted Average Cost of Capital (WACC)	12.74%
Revenue Per Employee	n/a
Profits Per Employee	-$1.16M
Employee Count	7
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.59% in the last 52 weeks. The beta is 1.54, so NanoViricides's price volatility has been higher than the market average.

Beta (5Y)	1.54
52-Week Price Change	-5.59%
50-Day Moving Average	1.26
200-Day Moving Average	1.29
Relative Strength Index (RSI)	60.78
Average Volume (20 Days)	1,550,736

Short Selling Information

The latest short interest is 713,649, so 3.13% of the outstanding shares have been sold short.

Short Interest	713,649
Short Previous Month	756,215
Short % of Shares Out	3.13%
Short % of Float	3.22%
Short Ratio (days to cover)	3.05

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-8.18M
Pretax Income	-8.09M
Net Income	-8.09M
EBITDA	-7.62M
EBIT	-8.18M
Earnings Per Share (EPS)	-$0.43

Balance Sheet

The company has $3.21 million in cash and n/a in debt, with a net cash position of $3.21 million or $0.14 per share.

Cash & Cash Equivalents	3.21M
Total Debt	n/a
Net Cash	3.21M
Net Cash Per Share	$0.14
Equity (Book Value)	9.15M
Book Value Per Share	0.42
Working Capital	2.31M

Cash Flow

In the last 12 months, operating cash flow was -$7.28 million and capital expenditures -$94,516, giving a free cash flow of -$7.37 million.

Operating Cash Flow	-7.28M
Capital Expenditures	-94,516
Depreciation & Amortization	556,663
Net Borrowing	n/a
Free Cash Flow	-7.37M
FCF Per Share	-$0.32

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NanoViricides does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-32.11%
Shareholder Yield	-32.11%
Earnings Yield	-23.52%
FCF Yield	-21.43%

Analyst Forecast

The average price target for NanoViricides is $6.00, which is 237.08% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.00
Price Target Difference	237.08%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 24, 2019. It was a reverse split with a ratio of 1:20.

Last Split Date	Sep 24, 2019
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	2